Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  11,745 results for ""Antibodies, Viral""

Your Filters

Subject : covid-19 Subject : emotional engagement Subject : psychological burnout
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster.

  • Authors : Li J; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.; Gong L

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/immunology COVID-19 breakthrough infectionsSARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3751-3755. Date of Electronic Publication: 2024 May 06.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: A retrospective cohort study.

  • Authors : Gröning R; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.; Walde J

Subjects: Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/therapeutic use ; Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/administration & dosage ; Immunocompromised Host*

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Jul; Vol. 144, pp. 107046. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

Read More Add to Saved list
×
Academic Journal

Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals.

  • Authors : da Costa HHM; Immunology Center, Institute Adolfo Lutz, São Paulo 01246-902, Brazil; Program Interunits in Biotechnology, University of São Paulo, São Paulo 05508-000, Brazil.

Subjects: Enzyme-Linked Immunosorbent Assay*/Enzyme-Linked Immunosorbent Assay*/Enzyme-Linked Immunosorbent Assay*/methods ; COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: Journal of immunological methods [J Immunol Methods] 2024 Jul; Vol. 530, pp. 113683. Date of Electronic Publication: 2024 May 15.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1305440 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Establishment of human post-vaccination SARS-CoV-2 standard reference sera.

  • Authors : Xiang J; Iowa City Veterans Administration Healthcare System, 601 Highway 6, Iowa City, IA 52246, USA; The University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology SARS-CoV-2 variants

  • Source: Journal of immunological methods [J Immunol Methods] 2024 Jul; Vol. 530, pp. 113698. Date of Electronic Publication: 2024 May 31.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1305440 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2.

  • Authors : Huang J; State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun 130062, China; Department of Chinese Medicine, The First Hospital of Jilin University, Changchun 130021, China.

Subjects: Rabies virus*/Rabies virus*/Rabies virus*/immunology ; Rabies virus*/Rabies virus*/Rabies virus*/genetics ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology SARS-CoV-2 variants

  • Source: Antiviral research [Antiviral Res] 2024 Jul; Vol. 227, pp. 105905. Date of Electronic Publication: 2024 May 11.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice.

  • Authors : Wang Z; Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China; College of Animal Science and Technology, College of Veterinary and Medicine, Jilin Agricultural University, Changchun, China.

Subjects: Influenza B virus*/Influenza B virus*/Influenza B virus*/immunology ; Influenza B virus*/Influenza B virus*/Influenza B virus*/genetics ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood

  • Source: Virus research [Virus Res] 2024 Jul; Vol. 345, pp. 199378. Date of Electronic Publication: 2024 Apr 23.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8410979 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Age dependent discrepancy between SARS-CoV-2 anti-nucleoprotein antibody and anti-RBD spike protein antibody in children reflects vaccine coverage.

  • Authors : Fujii Y; Department of Pediatrics, Hamamatsu University School of Medicine, Japan.; Ishigaki H

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Jul; Vol. 30 (7), pp. 646-650. Date of Electronic Publication: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The contributions of vaccination and natural infection to the production of neutralizing antibodies against the SARS-CoV-2 prototype strain and variants.

  • Authors : Xie H; Institute for Immunization and Prevention, Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing, China.; Zhang J

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology SARS-CoV-2 variants

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Jul; Vol. 144, pp. 107060. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

Read More Add to Saved list
×
Academic Journal

Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.

  • Authors : Chervo TC; Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America.; Elkin EP

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: PloS one [PLoS One] 2024 Jun 20; Vol. 19 (6), pp. e0303303. Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial.

  • Authors : Dinh Thiem V; Centre for Clinical Trials, National Institute of Hygiene and Epidemiology, Ha Noi, Viet Nam.; Van Anh PT

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects SARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2024 Jun 20; Vol. 42 (17), pp. 3699-3709. Date of Electronic Publication: 2024 May 10.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  11,745 results for ""Antibodies, Viral""